Article updated:
10/18/2012 11:45 AM
By Associated Press
LAFAYETTE, Ind. — Before federal agencies and state
lawmakers engage in any crackdown on regulations for specialty and compounding
pharmacies, those running such facilities have a message to share.
We’re different, they say, from the Massachusetts
manufacturer that produced 17,000 doses of a back pain steroid that is believed
to have caused 19 deaths and sickened at least 247 people nationwide.
While Indiana pharmacists who run custom compounding businesses are fielding questions left and right from clients and others about the safety of their products, experts say cries about pharmaceutical regulation in light of the nationwide scare over a fungal meningitis outbreak may be misguided.
“The public
fear is completely understandable, but people are taking it too far,” John
Herzig, medication safety project manager for the Purdue College of Pharmacy’s
Center for Medication Safety Advancement, told the Journal & Courier. “The whole
health community knows that compounding pharmacies serve a real important
service, and they do so much good.”
Continue reading here
No comments:
Post a Comment